Clinical Study to Evaluate Adherence Improvement Fixed-dose Combination of Olostar Tab. in Patients With Hypertension and Dyslipidemia

NCT04061824 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Hypertension
Dyslipidemias

Interventions

DRUG: Olostar Tab (olmesartan/rosuvastatin FDC(fixed dose combination))
DRUG: Two separated drugs(ARB(Angiotensin Ⅱ receptor blocker) and statin)

Sponsor

Yonsei University